Similar articles

• Intrinsic versus acquired drug resistance.

  Mackillop WJ. Mackillop WJ. Cancer Treat Rep. 1986 Jun;70(6):817-8. Cancer Treat Rep. 1986. PMID: 3731144 No abstract available.
• Introduction to resistance to anticancer agents.

  Kruh GD. Kruh GD. Oncogene. 2003 Oct 20;22(47):7262-4. doi: 10.1038/sj.onc.1206932. Oncogene. 2003. PMID: 14576836 Review. No abstract available.
• [Drug resistance and a strategy to eradicate resistant malignant cells].

  Shimoyama M. Shimoyama M. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1280-2. Gan To Kagaku Ryoho. 1989. PMID: 2730026 Japanese.
• Drug resistance modulation in the laboratory and the clinic.

  Dalton WS. Dalton WS. Semin Oncol. 1993 Feb;20(1):64-9. Semin Oncol. 1993. PMID: 8475411 Review. No abstract available.
• p53 and response to chemotherapy and radiotherapy.

  Ruley HE. Ruley HE. Important Adv Oncol. 1996:37-56. Important Adv Oncol. 1996. PMID: 8791127 Review. No abstract available.